Lorenzo G Mantovani
TitleCited byYear
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the …
T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1211-1259, 2017
6422017
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
G Mazzaglia, E Ambrosioni, M Alacqua, A Filippi, E Sessa, V Immordino, ...
Circulation 120 (16), 1598-1605, 2009
549*2009
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 …
SI Hay, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1260-1344, 2017
4892017
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational …
AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice, SZ Goldhaber, S Goto, ...
PloS one 8 (5), e63479, 2013
3612013
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
A Gringeri, B Lundin, S Von Mackensen, L Mantovani, PM Mannucci, ...
Journal of Thrombosis and Haemostasis 9 (4), 700-710, 2011
3582011
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
A Gringeri, LG Mantovani, L Scalone, PM Mannucci
Blood 102 (7), 2358-2363, 2003
3492003
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic …
E Gakidou, A Afshin, AA Abajobir, KH Abate, C Abbafati, KM Abbas, ...
The Lancet 390 (10100), 1345-1422, 2017
2912017
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care
G Mazzaglia, LG Mantovani, MCJM Sturkenboom, A Filippi, G Trifirò, ...
Journal of hypertension 23 (11), 2093-2100, 2005
2252005
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
VL Feigin, AA Abajobir, KH Abate, F Abd-Allah, AM Abdulle, SF Abera, ...
The Lancet Neurology 16 (11), 877-897, 2017
2162017
European principles of haemophilia care
BT Colvin, J Astermark, K Fischer, A Gringeri, R Lassila, W Schramm, ...
Haemophilia 14 (2), 361-374, 2008
1982008
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to …
C Fitzmaurice, TF Akinyemiju, FH Al Lami, T Alam, R Alizadeh-Navaei, ...
JAMA oncology 4 (11), 1553-1568, 2018
1932018
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
C Leissinger, A Gringeri, B Antmen, E Berntorp, C Biasoli, S Carpenter, ...
New England Journal of Medicine 365 (18), 1684-1692, 2011
1872011
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice, SZ Goldhaber, S Goto, ...
American heart journal 163 (1), 13-19. e1, 2012
1792012
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non …
W Ageno, LG Mantovani, S Haas, R Kreutz, D Monje, J Schneider, ...
The Lancet Haematology 3 (1), e12-e21, 2016
1562016
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of …
H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1084-1150, 2017
1552017
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
L Scalone, LG Mantovani, PM Mannucci, A Gringeri, ...
Haemophilia 12 (2), 154-162, 2006
1482006
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective
C Weil-Olivier, M van der Linden, I de Schutter, R Dagan, L Mantovani
BMC infectious diseases 12 (1), 207, 2012
1322012
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the …
RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ...
The Lancet 390 (10091), 231-266, 2017
1262017
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
C Hermans, C Altisent, A Batorova, H Chambost, P De Moerloose, ...
Haemophilia 15 (3), 639-658, 2009
1242009
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
AJ Camm, G Accetta, G Ambrosio, D Atar, JP Bassand, E Berge, F Cools, ...
Heart 103 (4), 307-314, 2017
1222017
The system can't perform the operation now. Try again later.
Articles 1–20